T. Kourouli

The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore model

S. Nikas, Sonyuan Lin, J. Grzybowska, 2004, The AAPS Journal.

Structure elucidation and conformational properties of synthetic cannabinoids (-)-2-(6a,7,10,10a-tetrahydro-6,6,9-trimethyl-1-hydroxy-6H-dibe nzo [b,d]pyranyl)-2-hexyl-1,3-dithiolane and its methylated analog.

T. Mavromoustakos, M. Zervou, D. Papahatjis, 1999, Journal of pharmaceutical and biomedical analysis.

Pharmacophoric requirements for cannabinoid side chains. Naphthoyl and naphthylmethyl substituted Δ8-tetrahydrocannabinol analogs†

A. Makriyannis, D. Papahatjis, T. Kourouli, 1996 .

A New Protocol for a Regioselective Aldol Condensation as an Alternative Convenient Synthesis of β-Ketols and α,β-Unsaturated Ketones

P. Kefalas, N. Ragoussis, T. Kourouli, 2002 .

The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.

Serdar Durdagi, Agnes Kapou, Thomas Mavromoustakos, 2007, Journal of medicinal chemistry.

Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.

S. Nikas, Wei Xu, A. Makriyannis, 2003, Journal of medicinal chemistry.

Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.

A. Makriyannis, A. Goutopoulos, D. Papahatjis, 1998, Journal of medicinal chemistry.

Behavioral pharmacological properties of a novel cannabinoid 1′,1′-dithiolane Δ8-THC analog, AMG-3

G. Panagis, C. Spyraki, K. Antoniou, 2005, Behavioural pharmacology.

Studies on the thermotropic effects of cannabinoids on phosphatidylcholine bilayers using differential scanning calorimetry and small angle X-ray diffraction.

M. Trumbore, A. Makriyannis, De‐Ping Yang, 1996, Biochimica et biophysica acta.